Salts of valsartan

Details for Australian Patent Application No. 2003214054 (hide)

Owner Novartis AG

Inventors Marti, Erwin

Agent Davies Collison Cave

Pub. Number AU-B-2003214054

PCT Number PCT/EP03/01047

PCT Pub. Number WO2003/066606

Priority 60/354,199 04.02.02 US

Filing date 3 February 2003

Wipo publication date 2 September 2003

Acceptance publication date 16 August 2007

International Classifications

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/354,199 04.02.02 US

25 September 2003 Application Open to Public Inspection

  Published as AU-B-2003214054

16 August 2007 Application Accepted

  Published as AU-B-2003214054

13 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003214055-METHOD FOR SCREENING FOR COMPOUNDS HAVING HDAC INHIBITORY ACTIVITY

2003214053-SYSTEM, METHOD AND TERMINAL FOR MEASURING THE QUALITY OF SERVICE IN A TELECOMMUNICATIONS NETWORK